Literature DB >> 15221783

DFold: PCR design that minimizes secondary structure and optimizes downstream genotyping applications.

David Fredman1, M Jobs, L Strömqvist, A J Brookes.   

Abstract

Secondary structures in polymerase chain reaction (PCR) target sequences have a negative impact on amplification success rates and on downstream uses of PCR products. For example, signal strength and allele discrimination in single nucleotide polymorphism (SNP) genotyping methods can be compromised by allele-biased amplification and/or by PCR product folding that limits access of interrogating probes. To increase the fidelity and robustness of PCR, and to aid follow-on applications, we have developed DFold (http://dfold.cgb.ki.se)-a generalized software solution that creates PCR oligonucleotide primer designs devoid of stable secondary structures. We demonstrate the effectiveness of the tool by applying it to a range of dynamic allele-specific hybridization (DASH) assay designs, many of which we evaluate in the laboratory. We further consider how the system throughput may be made sufficiently high for use upon millions of target sequences in order to support whole-genome analyses. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221783     DOI: 10.1002/humu.20066

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  3 in total

1.  Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.

Authors:  Sara Lindström; Fredrik Wiklund; Björn-Anders Jonsson; Hans-Olov Adami; Katarina Bälter; Anthony J Brookes; Jianfeng Xu; S Lilly Zheng; William B Isaacs; Jan Adolfsson; Henrik Grönberg
Journal:  Hum Genet       Date:  2005-09-28       Impact factor: 4.132

2.  Polymorphisms associated with asthma are inversely related to glioblastoma multiforme.

Authors:  Judith Schwartzbaum; Anders Ahlbom; Beatrice Malmer; Stefan Lönn; Anthony J Brookes; Hani Doss; Waldemar Debinski; Roger Henriksson; Maria Feychting
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

3.  A multi-target, non-infectious and clonable artificial positive control for routine PCR-based assays.

Authors:  Donna Ria J Caasi; Mohammad Arif; Mark Payton; Ulrich Melcher; Louise Winder; Francisco M Ochoa-Corona
Journal:  J Microbiol Methods       Date:  2013-09-05       Impact factor: 2.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.